BEAM EPS Estimates
Beam Therapeutics Inc.
$23.65
-$0.78(-3.19%)
43
Overall
60
Value
20
Tech
50
Quality
Market Cap
$2.44B
Volume
1.66M
52W Range
$20.23 - $38.26
Target Price
$48.11
BEAM EPS estimates: the consensus estimate for Beam Therapeutics Inc.'s current fiscal year is -$4.49 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BEAM EPS Estimates
- EPS estimate, current quarter
- $-1.16
- EPS estimate, next quarter
- $-1.24
- EPS estimate, current year
- $-4.49
- EPS estimate, next year
- $-5.05
- EPS growth, 3-year
- +41.90%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.81 |
| 2024 | $-4.58 |
| 2023 | $-1.72 |
| 2022 | $-4.13 |
| 2021 | $-5.77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BEAM | $23.65 | -3.2% | 1.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |